<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T12:02:21Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.33892" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.33892</identifier>
    <datestamp>2026-04-16T14:37:41Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-04-16</dc:date>
  <dc:title>Studies on Phenylalanine Metabolism in Enhancing the &amp;epsilon;-Polylysine-Mediated Killing Effect of Oxytetracycline-resistant Aeromonas hydrophila</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.33892</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Aims: Aeromonas hydrophila&amp;nbsp;is a zoonotic pathogen, and its prevalence of drug resistance underscores the urgency of elucidating alternative bactericidal strategies. This study employed the oxytetracycline-resistant strain OTC-A01 to investigate the bactericidal mechanism of &amp;epsilon;-PL. Methods and Results: With increasing &amp;epsilon;-PL concentration, the survival rate of OTC-A01 decreased to 0.101% at 100 &amp;mu;g/mL. SEM and membrane integrity assays confirmed that &amp;epsilon;-PL disrupted the membrane structure, leading to leakage of nucleic acids and proteins, increased AKP activity, and decreased relative conductivity, ATPase and NADH activity. Non-targeted metabolomics identified 142 differentially expressed metabolites, with S-plot analysis revealing 74 downregulated and 68 upregulated metabolites. KEGG enrichment indicated that the phenylalanine metabolism pathway was the most significantly affected, which was validated by RT-qPCR showing suppressed expression of key enzyme-encoding genes (DAADH, CAT, HPPD, AST). Notably, supplementation with downregulated exogenous metabolites significantly enhanced the bactericidal effect of &amp;epsilon;-PL, with 2-phenylacetamide exhibiting the strongest synergistic effect (up to 436-fold), at which point intracellular &amp;epsilon;-PL concentration reached 50.26 &amp;mu;g/mg protein. Conclusion: These results demonstrated the phenylalanine metabolic pathway is the key pathway through which &amp;epsilon;-PL exerts its bactericidal effect against OTC-A01. This study innovatively applied non-targeted metabolomics to identify this pathway as a critical metabolic target, and was the first to demonstrate that exogenous metabolite supplementation enhances&amp;nbsp;&amp;epsilon;-PL efficiency via metabolic reprogramming. This work uncovered a novel molecular mechanism of &amp;epsilon;-PL&amp;rsquo;s antibacterial activity and provides theoretical support for developing antimicrobial strategies targeting bacterial metabolism, with significance for addressing A. hydrophila&amp;nbsp;antibiotic resistance in aquaculture and public health.</dc:description>
  <dc:subject>ε-polylysine (ε-PL); Aeromonas hydrophila; metabolomics; oxytetracycline resistance; phenylalanine metabolism</dc:subject>
  <dc:creator>Danfeng Zhang</dc:creator>
  <dc:rights>EMBARGO</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nd/4.0</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>